Flurbiprofen, a propionic acid derivative, is a nonsteroidal anti-inflammatory agent (NSAIA) with antipyretic and analgesic activity. Oral formulations of flurbiprofen may be used for the symptomatic treatment of rheumatoid arthritis, osteoarthritis and anklylosing spondylitis. Flurbiprofen may also be used topically prior to ocular surgery to prevent or reduce intraoperative miosis. Flurbiprofen is structurally and pharmacologically related to fenoprofen, ibuprofen, and ketoprofen.
Flurbiprofen tablets are indicated for the acute or long-term symptomatic treatment of rheumatoid arthritis, osteorarthritis and anklosing spondylitis. It may also be used to treat pain associated with dysmenorrhea and mild to moderate pain accompanied by inflammation (e.g. bursitis, tendonitis, soft tissue trauma). Topical ophthalmic formulations may be used pre-operatively to prevent intraoperative miosis.
Cancer Hospital Chinese Academy of Medical Sciences, Beijing, China
CRS Clinical Research Services Berlin GmbH, Berlin, Germany
Beiing university of Chinese medicine Dongzhimen Hospital, Beijing, Beijing, China
CROSS Research S.A., Phase I Unit, Arzo, Switzerland
Volunteer recruitment center Covance Leeds Covance Leeds, Leeds, United Kingdom
beijing friendship hospital of Capital Medical university, Beijing, China
Peking University Hospital of Stomatology, Beijing, Beijing, China
Zijian Guo, Haidian, Beijing, China
GSK Investigational Site, Las Vegas, Nevada, United States
Abdullah AlAlwani, Mersin, Turkey
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.